SIGA Technologies Inc. (SIGA)
SIGA Technologies Inc. is a biopharmaceutical company specializing in the development and commercialization of antiviral medications. The company is known for its products targeting biothreat agents and infectious diseases, with a focus on treatments for smallpox and other orthopoxvirus infections. SIGA's flagship drug, TPOXX (tecovirimat), is an antiviral approved for the treatment of smallpox and has been developed to address potential bioweapons threats.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| May 15, 2025 | $0.60 | 2025-04-29 | 2025-04-29 |
| April 11, 2024 | $0.60 | 2024-03-25 | 2024-03-26 |
| June 1, 2023 | $0.45 | 2023-05-15 | 2023-05-16 |
| June 2, 2022 | $0.45 | 2022-05-16 | 2022-05-17 |
Dividends Summary
- SIGA Technologies Inc. has issued 4 dividend payments over the past 3 years
- The most recent dividend was paid 162 days ago, on May 15, 2025
- The highest dividend payed out to investors during this period was $0.60 per share
- The average dividend paid during this period was $0.53 per share.
Company News
Healthcare stocks have been stagnant since April, but offer attractive dividend yields ranging from 5.3% to 7.1%. The article highlights several healthcare REITs and pharmaceutical companies with high dividend potential despite market challenges.
SIGA Technologies reported strong Q2 2025 financial performance, with revenue jumping 271.6% to $81.1 million, driven by major TPOXX antiviral therapy deliveries to U.S. government agencies. The company paid a special $0.60 per share dividend and maintained robust cash reserves.
The sustainable construction materials market is predicted to reach $734.9 billion by 2032, driven by the growing adoption of green certifications and standards. Companies are focusing on team training and understanding green benchmarks to strengthen their position in the evolving market. However, the adoption of sustainable materials faces chall...
SIGA Technologies, Inc. (SIGA) is under investigation by the Law Offices of Howard G. Smith due to potential violations of federal securities laws. The investigation is related to the termination of the company's Chief Medical Officer and the subsequent release of a video revealing concerns about the company's Monkeypox treatment.
Siga Technologies Inc. (SIGA) closed the most recent trading day at $6.41, moving +1.42% from the previous trading session.